Adaptimmune Therapeutics PLC - SPONDS ADR (ADAP)

Q2 2021 13F Holders as of 6/30/2021

Type / Class
Equity / SPONDS ADR
Number of holders
80
Total Shares
112M
Shares change
-5.81M
Total reported value, excl. options
$476M
Value change
-$26.2M
Put/Call ratio
1.19
Number of buys
35
Number of sells
-33
Price
$4.26
Investor Option Weight % Change % Value $ * Price $ Shares Share Change Activity Report Period
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.